27245303|t|Dynamics of intestinal metabolites and morphology in response to necrotic enteritis challenge in broiler chickens
27245303|a|Despite the relatively small contribution to metabolizable energy that volatile fatty acids (VFAs) provide in chickens, these organic acids have been reported to play beneficial roles in the gastrointestinal tract (GIT) of birds, for example, inhibition of the growth of some pathogenic bacteria. However, information regarding the dynamics of these metabolites in the GIT of chickens is still scarce, especially under disease conditions such as necrotic enteritis (NE). Here, we investigated the dynamics of VFAs and lactic acid, and intestinal morphology in response to NE predisposing factors, that is, excessive dietary fishmeal and Eimeria inoculation, and causative agent Clostridium perfringens producing NetB toxin. The experiment was designed in a 2 × 2 × 2 factorial arrangement of treatments with or without: fishmeal feeding, Eimeria inoculation and C. perfringens challenge. The results showed that these factors significantly influenced composition and concentration of VFAs and lactic acids, pH and histomorphometry in one way or another. These changes may be important for the onset of NE or only the synergetic responses to micro environmental stress. Eimeria appeared to be more important than fishmeal in predisposing birds to NE, thus the application of Eimeria in NE challenge provides more consistent success in inducing the disease. The metabolic responses to various adverse factors such as excessive dietary fishmeal and Eimeria infection are complex. Thus, intensive efforts are required to better understand NE so as to achieve the control of the disease in the absence of antibiotics.
27245303	12	22	intestinal	T017	UMLS:C0021853
27245303	23	34	metabolites	T103	UMLS:C0870883
27245303	65	83	necrotic enteritis	T038	UMLS:C0267454
27245303	84	93	challenge	T058	UMLS:C0805586
27245303	97	113	broiler chickens	T204	UMLS:C2698565
27245303	185	205	volatile fatty acids	T103	UMLS:C0015691
27245303	207	211	VFAs	T103	UMLS:C0015691
27245303	224	232	chickens	T204	UMLS:C2698565
27245303	240	253	organic acids	T103	UMLS:C0369760
27245303	264	272	reported	T058	UMLS:C0700287
27245303	305	327	gastrointestinal tract	T022	UMLS:C0017189
27245303	329	332	GIT	T022	UMLS:C0017189
27245303	337	342	birds	T204	UMLS:C0005595
27245303	357	381	inhibition of the growth	T038	UMLS:C2249823
27245303	401	409	bacteria	T007	UMLS:C0004611
27245303	464	475	metabolites	T103	UMLS:C0870883
27245303	483	486	GIT	T022	UMLS:C0017189
27245303	490	498	chickens	T204	UMLS:C2698565
27245303	533	551	disease conditions	T033	UMLS:C1299555
27245303	560	578	necrotic enteritis	T038	UMLS:C0267454
27245303	580	582	NE	T038	UMLS:C0267454
27245303	623	627	VFAs	T103	UMLS:C0015691
27245303	632	643	lactic acid	T103	UMLS:C0064582
27245303	649	659	intestinal	T017	UMLS:C0021853
27245303	686	688	NE	T038	UMLS:C0267454
27245303	730	737	dietary	T168	UMLS:C0012155
27245303	751	758	Eimeria	T204	UMLS:C0013739
27245303	759	770	inoculation	T058	UMLS:C2987620
27245303	776	791	causative agent	T033	UMLS:C0449411
27245303	792	815	Clostridium perfringens	T007	UMLS:C0009063
27245303	826	836	NetB toxin	T103	UMLS:C3492213
27245303	842	852	experiment	T062	UMLS:C0205664
27245303	857	865	designed	T062	UMLS:C0015320
27245303	891	902	arrangement	T058	UMLS:C0586001
27245303	906	916	treatments	T058	UMLS:C0087111
27245303	952	959	Eimeria	T204	UMLS:C0013739
27245303	960	971	inoculation	T058	UMLS:C2987620
27245303	976	990	C. perfringens	T007	UMLS:C0009063
27245303	991	1000	challenge	T058	UMLS:C0805586
27245303	1065	1076	composition	T201	UMLS:C0486616
27245303	1098	1102	VFAs	T103	UMLS:C0015691
27245303	1107	1119	lactic acids	T103	UMLS:C0064582
27245303	1216	1218	NE	T038	UMLS:C0267454
27245303	1275	1281	stress	T033	UMLS:C0038435
27245303	1283	1290	Eimeria	T204	UMLS:C0013739
27245303	1351	1356	birds	T204	UMLS:C0005595
27245303	1360	1362	NE	T038	UMLS:C0267454
27245303	1388	1395	Eimeria	T204	UMLS:C0013739
27245303	1399	1401	NE	T038	UMLS:C0267454
27245303	1402	1411	challenge	T058	UMLS:C0805586
27245303	1461	1468	disease	T038	UMLS:C0012634
27245303	1505	1512	adverse	T038	UMLS:C0879626
27245303	1539	1546	dietary	T168	UMLS:C0012155
27245303	1560	1567	Eimeria	T204	UMLS:C0013739
27245303	1568	1577	infection	T038	UMLS:C3714514
27245303	1607	1614	efforts	T038	UMLS:C0015264
27245303	1638	1648	understand	T038	UMLS:C0162340
27245303	1649	1651	NE	T038	UMLS:C0267454
27245303	1673	1695	control of the disease	T058	UMLS:C0085557
27245303	1714	1725	antibiotics	T103	UMLS:C0003232